NF-κB and chemoresistance: Potentiation of cancer chemotherapy via inhibition of NF-κB

Drug Resistance Updates

Volumn 2, Issue 4, 1999, Pages 271-273

  Cusack, James C ^a,b   Liu, Rong ^a   Baldwin, Albert S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CANCER; CANCER CHEMOTHERAPY; DRUG CYTOTOXICITY; DRUG SENSITIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033177897     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0094     Document Type: Article

References (21)

1. Baldwin AS. The NF-κB and IκB proteins: New discoveries and insights. Ann Rev Immunol 1996; 14: 649-681.
2. Ghosh S, May MJ, Kopp EB. NF-κB and rel proteins: Evolutionary conserved mediators of immune responses. Ann Rev Immunol 1998; 16: 225-260.
3. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 1995; 376: 167-170.
4. Wang C-Y, Mayo MW, Baldwin AS. TNF- and cancer therapy- Induced apoptosis: Potentiation by inhibition of NF-κB. Science 1996; 274: 784-787.
5. Beg, AA And Baltimore D. An essential role for NF-κB in preventing TNFα-induced cell death. Science 1996; 276: 782-784.
6. Van Antwerp D, Martin SJ, Kafri T, Green, DR. And Verma, I. Suppression of TNFα-induced apoptosis by NF-κB. Science 1996; 276: 787-789.
7. Liu ZG, Hsu H, Goeddel DV, and Karin M. Dissection of TNF receptor I effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996; 87: 565-576.
8. Arsura M, Wu M, and Sonenshein GE. TGFβI inhibits NF-κB/Rel activity inducing apoptosis of B-cells: Transcriptional activation of IκBα. Immunity 1996; 5: 31-40.
9. Wang C-Y, Mayo MW, Korneluk RW, Goeddel DV, and Baldwin AS. NF-κB anti-apoptosis: Induction of TRAF1 and 2 and c-IAP 1 and 2 to suppress caspase-8 activation. Science 1998; 276: 1680-1683.
10. Wu MX, Ao Z, Prasad KVS, Wu R, and Schlossman SF. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science 1998; 281: 998-1001.
11. Stehlik C, de MaRtin R, Kumabashiri I, Schmid J, Binder B, and Lipp J. NF-κB-regulated XIAP gene expression protects endothelial cells from TNFα-induced apoptosis. J Exp Med 1998; 188: 211-216.
12. Zong MX, Edelstein LC, Chen C, Bash J and Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/AI is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis. Genes and Dev 1999; 13: 382-387.
13. Grumont RJ, Rourke Ij, and Gerondakis S. Rel-dependent induction of AI transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes and Dev 1999; 13: 400-411.
14. Wang C-Y, Guttridge D, Mayo MW and Baldwin AS. NF-κB induces expression of the Bcl-2 homologue AI/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. In press 1999; Mol Cell Biol.
15. Kasibhatla S, Genestier L, and Green DR. Regulation of Fas-ligand expression during actrivation-induced cell death in T lymphocytes via NF-κB. J Biol Chem 1999; 274: 987-992.
16. Wang C-Y, Cusack JC, Liu R, and Baldwin AS. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nature Medicine 1999;4: 412-417.
17. Bentires-Alj M, Hellin A-C, Ameyar M, Chouaib S, Merville M-P and Bours V. Stable inhibition of NF-κB in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res 1999; 59: 811-815.
18. Mayo MW et al. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 1997; 278: 1812-1815.
19. Bargou RC et al. Constitutive NF-κB/RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Inv 1997; 100: 2961-2969.
20. Sovak M. et al. Aberrant NF-κB/Rel expression and the pathogenesis of breast cancer. J Clin Inv 1997; 100: 2952-2960.
21. Sumitomo M et al. Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IκBα overexpression. Human Gene Therapy 1999; 10: 37-47.